Reporting of the assay
Percent survival (potential therapeutic efficacy) was calculated relative to appropriate negative and positive controls for each treatment. Efficacy and resistance of each drug and combinations were reported on the ChemoID assay results as a continuous number from <10% to 100% cell-kill as previously.